Currently viewing the tag: "Torpotarget"
Last week saw the publication of a paper on TopoTarget ‘s Berlinostat in Pancreatic Cancer. The paper was accepted after clarification on some of the points mentioned by the reviewer –
The combination of belinostat and gemcitabine has some additive effect in vitro, yet not synergic nor significant neither confirmed by in vivo experiments.
In […]
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard

